NovoSeven Articles
Avantogen CEO joins Hawaii Biotech board
27 October 2008
Bayer licenses Sartorius' UVivatec
27 October 2008
PharmAthene gets $1.6M to continue Protexia development
20 October 2008
Bayer's Factor VIII drug gets FDA go-ahead
20 October 2008
OctoPlus in $149M deal with Biolex
13 October 2008
UPDATE: $3 billion for global malaria campaign
6 October 2008
$84M for PharmAthene
6 October 2008
Dyax completes BLA for DX-88 in HAE
29 September 2008
Affitech achieves second Roche milestone
29 September 2008
Biopartners' growth hormone, 3-year data
29 September 2008
Novavax' VLP flu vaccine enters Ph II trial
29 September 2008
Japan's MHLW consults on biosimilars
29 September 2008
Orphan status in EU for Alseres' Cethrin
29 September 2008
Novo Nordisk changes NovoSeven formulation
22 September 2008
Trillium secures C$12M financing
22 September 2008
Emergent gets HHS nod for Anthrax vacc contract
22 September 2008
Takeda reigns supreme among Japanese pharma companies
22 September 2008
FDA priority review for GTC's Atryn
15 September 2008
Orphan status for ProtAffin's PA401
15 September 2008
Bayer Schering submits European marketing application for Recothrom
8 September 2008
Sandoz gets FDA approval for Omnitrope
8 September 2008
Stock Commentary - Europe - week to Sept 1, 2008
8 September 2008
Hawaii Biotech gets support for Dengue vaccine program
8 September 2008
Testing for purified bulk drug subs and sterile liquids explained
8 September 2008
PDCO gives word on PIPs from latest meeting
1 September 2008
Novo Nordisk's 2nd-qtr 2008 profit falls 32%
18 August 2008
GTC completes BLA filing for ATryn
18 August 2008
Restructing costs hit Biovitrum's first half
4 August 2008
Thermo Fisher acquires Affinity BioReagents
28 July 2008
Eight drugs get nod from EMEA's COMP
21 July 2008
Cytheris gets $2.4M no interest loan from OSEO
21 July 2008
Japan stock market week to July 14, 2008
21 July 2008
S-P fertility treatment achieves equivalence
14 July 2008
Nordic files patent suit against Oxford Biomed
14 July 2008
Bayer buys Maxygen portfolio for $120M
7 July 2008
ZymoGenetics secures $100M funding
7 July 2008
Pharming acquires licenses to key fibrinogen patents
30 June 2008
Generex Oral-lyn non-inferior to insulin analogs
30 June 2008
Repligen in profit for year-ending 2008
23 June 2008
Novo Nordisk discontinues Ph III NovoSeven trial
16 June 2008
Cancer death risk label for J&J's Regranex
16 June 2008
Emergent BioSol gets PSC assets for $78M
2 June 2008
Japan stock market week to May 26, 2008
2 June 2008
Strong Ph II data for Novartis' MenB vacc
26 May 2008
Meridian to acquire antigens from Vybion
19 May 2008
ZymoGenetics' 1st-qtr loss widens 22.8%
19 May 2008
Alseres cuts Cethrin payouts to BioAxone
12 May 2008
Emergent Bio in anthrax vacc deal
12 May 2008
EUSA divests MAb and other research
12 May 2008
Gene Bridges licenses Red/ET to Novozymes
5 May 2008
Amgen's AMG 386 aids tumor growth reduction
21 April 2008
COMP recommends OD status for eight drugs
21 April 2008
CSL Behring enters deal for Canada
14 April 2008
CSL Behring licenses Novozymes' albufuse
14 April 2008
ARCA renames to reflect new focus
7 April 2008
FDA launches safety review of J&J's Regranex
7 April 2008
Pharming grants EIP rights to Rhucin in Turkey
31 March 2008
Pharming to resubmit Rhucin MAA
31 March 2008
Merck & Co's Gardasil gets priority US review
31 March 2008
PharmAthene to buy Avecia business
31 March 2008
Pre-filled syringe use growing in range of therapies
10 March 2008
Bayer's 4th-qtr 2007 profit plummets 76% to 67M euros, well below analyst expectations
10 March 2008
Ipsen's 2007 operating profit climbs 12%
10 March 2008
Japan stock market week to Feb 25, 2008
3 March 2008
MorphoSys and Sigma-Aldrich collaborate
3 March 2008
Biovitrum's earnings flat on expenses
3 March 2008
FDA approves Wyeth's hemophilia A drug
3 March 2008
Millipore in technology deal with Bayer
3 March 2008
Pharming's 2007 loss doubles on costs
25 February 2008
Novozymes and Upperton extend deal
25 February 2008
Sanofi Pasteur teams up with Denmark's SSI for TB vaccines
25 February 2008
S-P's 4th-qtr 2007 results hit by Organon buy
18 February 2008
Cytogen announces development initiative for oncology products
4 February 2008
Ipsen abandons EU NutropinAq application
4 February 2008
Baxter's 4th-qtr income climbs 11%
4 February 2008
Tercica begins dosing in Ph II IGF-1 deficiency trial
4 February 2008
Bayer USA withdraws Leukine 500mcg vials
4 February 2008
Protalix extends AChE deal with Yissum
28 January 2008
Pfizer licenses Scil's rhCD-RAP
28 January 2008
Recothrom approved by the FDA
28 January 2008
ARTES enters long-term accord with Minapharm
21 January 2008
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
